Created at	Source	Raw Value	Validated value
June 25, 2024, noon	usa	* type 2 respiratory failure; * hemodynamic instability requiring vasopressors and/or inotropes support; * ct evidence of pneumothorax/pneumomediastinum; * concomitant acute medical disease (stroke; myocardial infarction; septic shock; gastrointestinal bleeding; acute renal failure requiring dialysis)	* type 2 respiratory failure; * hemodynamic instability requiring vasopressors and/or inotropes support; * ct evidence of pneumothorax/pneumomediastinum; * concomitant acute medical disease (stroke; myocardial infarction; septic shock; gastrointestinal bleeding; acute renal failure requiring dialysis)
Jan. 7, 2022, 8 a.m.	usa	type 2 respiratory failure; hemodynamic instability requiring vasopressors and/or inotropes support; ct evidence of pneumothorax/pneumomediastinum; concomitant acute medical disease (stroke; myocardial infarction; septic shock; gastrointestinal bleeding; acute renal failure requiring dialysis)	type 2 respiratory failure; hemodynamic instability requiring vasopressors and/or inotropes support; ct evidence of pneumothorax/pneumomediastinum; concomitant acute medical disease (stroke; myocardial infarction; septic shock; gastrointestinal bleeding; acute renal failure requiring dialysis)